CareDx, Inc.Equity-NMS: CDNA
Equity-NMS: CDNA
$24.5
+0.52
(3 Aug)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$24.50
Open
$24.50
52W high
$84.94
1Y
2.17%
5Y
-6.74%
Shares O/S
53.22M
Market cap
1.3B
Insights
No insights found for this stock
Compare with other stock
Price
1D
PE
Market cap
About CareDx, Inc.

CareDx, Inc. is a precision medicine company. The Company is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The Company offers testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients.

Its commercially available testing services consist of AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its suite of AlloSeq products include AlloSeq Tx, AlloSeq cfDNA, AlloSeq HCT, TruSight HLA, Olerup SSP and QTYPE. It develops and provides diagnostic surveillance testing services for various transplant recipients. .


FAQs

Can I buy CareDx, Inc. shares in India?
How to buy CareDx, Inc. shares in India?
What is the share price of CareDx, Inc.?
What is the Market Capitalization of CareDx, Inc.?
What is the PE ratio of CareDx, Inc.?
Is CareDx, Inc. a good stock to buy?
In which sector / industry does CareDx, Inc. operate?